MannKind Corp
MNKD
#4917
Rank
HK$13.57 B
Marketcap
HK$44.22
Share price
-0.53%
Change (1 day)
-15.57%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): HK$0.23 Billion

According to MannKind Corp's latest financial reports the company's current earnings are HK$0.31 Billion. In 2024 the company made an earning of HK$0.23 Billion, an increase over its 2023 earnings that were of -HK$80.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.23 B0.78%
2024 HK$0.23 B-394.09%
2023 -HK$80.79 Million-88.13%
2022 -HK$0.69 Billion8%
2021 -HK$0.63 Billion40.84%
2020 -HK$0.45 Billion10.7%
2019 -HK$0.41 Billion-40.16%
2018 -HK$0.68 Billion-26.04%
2017 -HK$0.92 Billion-193.33%
2016 HK$0.97 B-134.11%
2015 -HK$2.87 Billion85.72%
2014 -HK$1.55 Billion3.6%
2013 -HK$1.5 Billion12.79%
2012 -HK$1.33 Billion5.58%
2011 -HK$1.26 Billion-5.72%
2010 -HK$1.33 Billion-22.51%
2009 -HK$1.72 Billion-27.37%
2008 -HK$2.36 Billion3.36%
2007 -HK$2.29 Billion27.18%
2006 -HK$1.8 Billion101.63%
2005 -HK$0.9 Billion50.46%
2004 -HK$0.6 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Halozyme Therapeutics
HALO
HK$5.80 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$162.27 B 67,618.55%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
HK$179.74 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.18 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$0.89 Billion-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA